Asthma affects more than 20 million adults in the U.S. and up to 10 percent of all asthma patients have severe asthma – in fact, each day 10 Americans will die from asthma. If people with asthma feel anxious about doing household chores, running errands or taking a walk because of fear of another asthma attack, this may be their “asthma Aha!” moment signaling a need to find out if asthma is a bigger part of their life than they think.
Not everyone experiences asthma the same way and symptoms can change over time. Even if someone thinks their asthma is under control, it might not be and it may be a more severe form of asthma. If a person with asthma has made one or more trips to urgent care, the emergency room or a hospital; experienced two or more asthma attacks in a year; or has symptoms that cause wake ups at night and interfere with daily activities–now is the time to consider the reason why.
Severe asthma can also be linked to eosinophils, a type of white blood cell. Almost 50% of people who have severe asthma have an increase of eosinophils in their lungs, which could cause more frequent asthma attacks. Getting the right treatment at the right time for severe asthma is important because repeated asthma flare ups and inflammation caused by long-term uncontrolled asthma may lead to lung damage.
Severe asthma doesn’t have to keep people from living life. Find out about the available treatment options for severe asthma that can help reduce eosinophils counts and symptoms. If someone has had an “asthma Aha!” moment, they can take action, visit asthma.com, download the asthma e-guide to track their asthma, gain better control and have a more meaningful conversation with their doctor.
Join me in a recent interview with Dr. David Slade, a national asthma expert, pulmonologist and GSK Medical Affairs Lead on Asthma, and severe asthma patient, Donna Matlach, who is a a ballroom dancer and co-founder of the Severe Asthma Foundation as they discuss:
● What is asthma and who does it affect most?
● How severe asthma is different than asthma and what causes it.
● Advice to help patients who may be struggling to manage their asthma.
● Donna’s asthma journey
● Donna’s “Asthma Aha!” moment and when she took action to treat it.
See the entire interview here: https://youtu.be/gPtIIEgR2vY
For more information, go to http://www.asthma.com.
Bio for David J. Slade, MD
US Asthma and Biologic Hub Leader
David completed his medical degree, pediatric residency, and chief residency at the State University of New York Health Science Center in Syracuse. Afterward he completed a pediatric pulmonology fellowship at Duke University Medical Center, funded by a National Institute of Child Health and Development training grant. His research there was focused on translational models of human airway remodeling and innate host lung defense. Prior to joining GSK, David held medical directorships in respiratory research and development at Teva and Astra Zeneca, where he led multiple Phase 2 and 3 studies; he also served as the vice president of research and development in rare diseases for Therakos. At GSK he leads the US medical affairs teams supporting the asthma portfolio.
This interview segment is courtesy of GlaxoSmithKline